Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2021 Jul;479(1):33-43.
doi: 10.1007/s00428-021-03040-6. Epub 2021 Jan 27.

Morphological intratumor heterogeneity in ductal carcinoma in situ of the breast

Affiliations
Comparative Study

Morphological intratumor heterogeneity in ductal carcinoma in situ of the breast

Claudia Stanciu-Pop et al. Virchows Arch. 2021 Jul.

Abstract

Ductal carcinoma in situ (DCIS) of the breast is a heterogeneous disease in terms of morphological characteristics, protein expression profiles, genetic abnormalities, and potential for progression. Molecular heterogeneity has been extensively studied in DCIS. Yet morphological heterogeneity remains relatively undefined. This study investigated morphological intratumor heterogeneity in a series of 51 large DCIS. Nuclear atypia, DCIS architecture, necrosis, calcifications, stromal architecture, and stromal inflammation were assessed in one biopsy slide and three representative slides from each corresponding resection. For each histopathological feature, a histo-score was determined per slide and compared between the biopsy and the resection, as well as within a single resection. Statistical analysis comprised of Friedman tests, post hoc Wilcoxon tests with Bonferroni corrections, Mann-Whitney U tests, and chi-square tests. Despite substantial morphological heterogeneity in around 50% of DCIS, the histopathological assessment of the biopsy did not statistically significantly differ from the resection. Morphological heterogeneity was not significantly associated with patient age, DCIS size, or type of surgery, except for a weak association between heterogeneous stromal inflammation and smaller DCIS size. At the group level, the degree of heterogeneity did not significantly affect the representativity of a biopsy. At the individual patient level, however, the presence of necrosis, intraductal calcifications, myxoid stromal changes, and high-grade nuclear atypia was underestimated in a minority of DCIS patients. This study confirms the presence of morphological heterogeneity in DCIS for all six evaluated histopathological features. This should be kept in mind when taking biopsy-based treatment decisions for DCIS patients.

Keywords: Breast; Ductal carcinoma in situ; Histopathology; Intratumor heterogeneity; Tumor-infiltrating lymphocytes.

PubMed Disclaimer

Similar articles

References

    1. McCormick B, Winter K, Hudis C, Kuerer HM, Rakovitch E, Smith BL, Sneige N, Moughan J, Shah A, Germain I, Hartford AC, Rashtian A, Walker EM, Yuen A, Strom EA, Wilcox JL, Vallow LA, Small W Jr, Pu AT, Kerlin K, White J (2015) RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation. J Clin Oncol 33:709–715 - PubMed - PMC - DOI
    1. Ward EM, DeSantis CE, Lin CC et al (2015) Cancer statistics: breast cancer in situ. CA Cancer J Clin 65:481–495 - PubMed - DOI - PMC
    1. Chen XY, Yeong J, Thike AA, Bay BH, Tan PH (2019) Prognostic role of immune infiltrates in breast ductal carcinoma in situ. Breast Cancer Res Treat 177:17–27 - PubMed - DOI - PMC
    1. Allred DC, Mohsin SK, Fuqua SAW (2001) Histological and biological evolution of human premalignant breast disease. In: Endocrine-Related Cancer. Endocr Relat Cancer, pp 47–61
    1. Agahozo MC, Westenend PJ, van Bockstal MR et al (2020) Immune response and stromal changes in ductal carcinoma in situ of the breast are subtype dependent. Mod Pathol 33:1173–1782

Publication types

LinkOut - more resources